EVHNYSEServices-Management ServicesFiscal year ends December 31
Evolent Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$4.48−0.09 (-1.97%)
Close on Oct 19, 2026
- Market cap
- $504.19M
- P/E (TTM)
- –
- Dividend yield
- –
Evolent Health, Inc. revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Evolent Health Services Segment | $652.52M | $496.25M | $468.72M | $479.53M | $444.33M | $483.65M | $646.54M | $621.40M | $647.15M | $639.65M | $556.06M | $511.02M | 100.0% | +46.9% |
| Reportable segment | $652.52M | $496.25M | $468.72M | $479.53M | $444.33M | $483.65M | $646.54M | $621.40M | $647.15M | $639.65M | – | – | 100.0% | +46.9% |
By product or service
By region
From the segment and revenue-disaggregation notes of Evolent Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.